BlossomHill Therapeutics Stock

bhtherapeutics.comHealthcare / BioTech & PharmaFounded: 2020

BlossomHill Therapeutics is a small molecule drug design and development company focused on a mission to address unmet medical needs in oncology and autoimmune diseases. With a deep pipeline of candidates across a range of targets, the company aims to take the next leap forward in treatment for patients. BlossomHill Therapeutics was founded by J. Jean Cui and Y. Peter Li in 2020 and is headquartered in San Diego, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for BlossomHill Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access BlossomHill Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like BlossomHill Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Yishan Li Ph.D
Jingrong Cui Ph.D
Scientific Co-Founder

Frequently Asked Questions About BlossomHill Therapeutics’ Stock

Can you buy BlossomHill Therapeutics’ stock?
BlossomHill Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy BlossomHill Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell BlossomHill Therapeutics’ stock?
Yes, you can sell stock of a private company like BlossomHill Therapeutics. Forge can help you sell your BlossomHill Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is BlossomHill Therapeutics’ stock price?
BlossomHill Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access BlossomHill Therapeutics’ private market stock price with Forge Data.
What is BlossomHill Therapeutics’ stock ticker symbol?
BlossomHill Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

BlossomHill Therapeutics Closes $100 Million Series B Financing
In a series B funding round led by Colt Ventures, BlossomHill raised $100 million.
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.